PRODUCT FOCUS :: ANTIBODY TESTS.
- Published in:
- 2024
- Publication type:
- Product Review
Works matching IS 05807247 AND DT 2024 AND VI 56 AND IP 2
Results: 10
1
2
Details from AMP on LDTs/LDPs.
- Published in:
- Medical Laboratory Observer (MLO), 2024, v. 56, n. 2, p. 35
- By:
- Publication type:
- Article
3
Advancing standards in laboratory medicine and pathology through professional credentials.
- Published in:
- Medical Laboratory Observer (MLO), 2024, v. 56, n. 2, p. 32
- By:
- Publication type:
- Article
4
A new twist: How the COVID-19 pandemic paved the way for increased molecular testing of hepatitis.
- Published in:
- Medical Laboratory Observer (MLO), 2024, v. 56, n. 2, p. 30
- By:
- Publication type:
- Article
5
CMS' coverage of HbA1c testing for diabetes screening is a good start - But we can do more.
- Published in:
- Medical Laboratory Observer (MLO), 2024, v. 56, n. 2, p. 22
- By:
- Publication type:
- Article
6
HIV epidemic: From the origin towards the end.
- Published in:
- Medical Laboratory Observer (MLO), 2024, v. 56, n. 2, p. 14
- By:
- Publication type:
- Article
7
Revealing the therapeutic potential of novel drugs for HPV-positive head and neck cancer.
- Published in:
- Medical Laboratory Observer (MLO), 2024, v. 56, n. 2, p. 10
- By:
- Publication type:
- Article
8
The changing respiratory testing landscape: Why the value of flexibility is key.
- Published in:
- Medical Laboratory Observer (MLO), 2024, v. 56, n. 2, p. 6
- By:
- Publication type:
- Article
9
CLIA Updates.
- Published in:
- Medical Laboratory Observer (MLO), 2024, v. 56, n. 2, p. 4
- By:
- Publication type:
- Article
10
Overcoming data management challenges: The biggest challenge of all is... us.
- Published in:
- Medical Laboratory Observer (MLO), 2024, v. 56, n. 2, p. 18
- By:
- Publication type:
- Article